MedPath

CDC ENTEBBE

🇺🇬Uganda
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

282

Active:3
Completed:251

Trial Phases

5 Phases

Phase 1:33
Phase 2:54
Phase 3:21
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (260 trials with phase data)• Click on a phase to view related trials

Not Applicable
109 (41.9%)
Phase 2
54 (20.8%)
Phase 4
43 (16.5%)
Phase 1
33 (12.7%)
Phase 3
21 (8.1%)

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

Phase 1
Recruiting
Conditions
Rotavirus Infections
Interventions
Biological: 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
Biological: 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
Other: Placebo
First Posted Date
2025-05-08
Last Posted Date
2025-07-03
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
50
Registration Number
NCT06962904
Locations
🇺🇸

Emory Children's Center - Vaccine Research Clinic, Atlanta, Georgia, United States

Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children

Not Applicable
Completed
Conditions
Enhanced Child-safety Packaging
First Posted Date
2025-04-22
Last Posted Date
2025-04-22
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
120
Registration Number
NCT06938620

CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

Phase 1
Active, not recruiting
Conditions
Rotavirus Infections
Interventions
Biological: 7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
Biological: 3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)
Other: Placebo
First Posted Date
2024-07-03
Last Posted Date
2025-07-02
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
50
Registration Number
NCT06485258
Locations
🇺🇸

Emory Children's Center - Vaccine Research Clinic, Atlanta, Georgia, United States

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

Phase 4
Completed
Conditions
Malaria
Plasmodium Falciparum
Uncomplicated Malaria
Interventions
Drug: Amodiaquine-artesunate (ASAQ)
Drug: Artemether+Lumefantrine (AL)
First Posted Date
2024-03-08
Last Posted Date
2024-05-07
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
352
Registration Number
NCT06300970
Locations
🇱🇷

Sinje Health Center, Garwula District, Sinje, Grand Cape Mount County, Sinje, Grand Cape Mount County, Liberia

🇱🇷

Saclepea-Mahn Comprehensive Health Center Saclepea-Mahn District, Nimba County, Saclepea, Nimba County, Liberia

Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP

Phase 3
Active, not recruiting
Conditions
Influenza
Interventions
Biological: FluQuadri
First Posted Date
2023-09-26
Last Posted Date
2025-05-29
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
192
Registration Number
NCT06054269
Locations
🇵🇪

Hospital Nacional Arzobispo Loayza, Lima, Peru

🇵🇪

Hospital Nacional Cayetano Heredia, Lima, Peru

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 56
  • Next

News

Updated COVID-19 Vaccines Show Strong Protection Against Severe Illness in Comprehensive CDC Study

A comprehensive CDC VISION Network study spanning over 345,000 emergency department encounters and 111,000 hospitalizations found that 2023-2024 COVID-19 vaccines reduced critical illness risk by 48% during the first seven to 299 days after vaccination.

Rutgers Study Challenges FDA Heart Safety Warning for Epilepsy Drug Lamotrigine

Rutgers Health researchers found lamotrigine safe in older adults with epilepsy, contradicting a 2020 FDA safety warning about potential heart risks.

Trump Administration Halts Major HIV Vaccine Research Programs Despite Scientific Progress

The Trump administration has terminated funding for multiple HIV vaccine research programs, including major efforts at Duke Human Vaccine Institute and Scripps Research Institute that have been running since 2012.

MAHA Commission Proposes Comprehensive Pediatric Drug Safety Research Initiative

The MAHA Commission has outlined an enhanced research framework focused on drug safety in pediatric populations, addressing critical gaps in current safety monitoring systems.

FDA Overhauls COVID-19 Vaccine Approval Process, Limiting Access for Healthy Adults and Children

The FDA has announced major changes to COVID-19 vaccine approvals, requiring placebo-controlled clinical trials for shots intended for healthy adults and children, effectively ending routine annual approvals for these groups.

UIC Researchers Develop Groundbreaking Antibiotic Against Superbugs as Illinois Faces Rising Antimicrobial Resistance

University of Illinois Chicago researchers have developed a novel antibiotic that could make it 100 million times harder for bacteria to develop resistance, potentially revolutionizing treatment of drug-resistant infections.

EMA Suspends Valneva's IXCHIQ Chikungunya Vaccine for Elderly Following Safety Concerns

European Medicines Agency has suspended the use of Valneva's IXCHIQ chikungunya vaccine in people over 65 years old following reports of 17 serious adverse events, including two deaths, in elderly patients.

Home Administration of Long-Acting HIV Injectable Therapy Proves Safe and Effective as Clinic Treatment

A study by the Medical University of South Carolina demonstrates that home administration of long-acting injectable antiretroviral therapy (ART) for HIV patients is as safe and effective as clinic-based administration.

Pneumonia Antibiotic Piperacillin Shows Promise as Targeted Lyme Disease Treatment at 100-Fold Lower Doses

Northwestern University researchers screened nearly 500 FDA-approved compounds and identified piperacillin as a potentially more effective Lyme disease treatment than current standard doxycycline therapy.

U.S. Measles Outbreak Reaches 800 Cases, Marking Largest Since Disease Elimination in 2000

The United States is experiencing its largest measles outbreak since the disease was declared eliminated in 2000, with at least 800 confirmed cases nationwide and likely more unreported.

© Copyright 2025. All Rights Reserved by MedPath